Ondansetron
Product Images NDC 67296-1321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-1321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30)

Package Label-principal Display Panel (4 mg (30)
Label for Ondansetron Orally Disintegrating Tablets USP 4 mg, indicating a bottle of 30 tablets. The label includes a barcode, drug dosage details, storage instructions, and manufacturer information, showing that it is distributed by Aurobindo Pharma USA, Inc., and made in India. The product is prescription-only and meets USP Disintegration Test 2.*
FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))
Ondansetron Orally Disintegrating Tablets USP 4 mg packaging label showing a carton containing 30 tablets (3 blister cards of 10 tablets each). The label includes storage instructions, a warning about phenylalanine content, dispensing guidelines, and illustrated administration instructions. Distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))
Ondansetron Orally Disintegrating Tablets, USP 8 mg bottle label by Redpharm Drug, containing 30 tablets. The label includes dosage strength, phenylketonurics content, storage instructions, and distributor information for Aurobindo Pharma USA, Inc. The label also features the NDC 65862-391-30 and a barcode.*
FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))
Packaging label for Ondansetron Orally Disintegrating Tablets, USP 8 mg by Aurobindo Pharma. The label indicates a count of 30 tablets in 3 blister cards, each containing 10 tablets. The label includes dosage form instructions and warnings about blister integrity and child-resistant packaging. Distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron showing its molecular framework with characteristic rings and functional groups consistent with its known molecular formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.